VOGLIDIN GM3

VOGLIDIN GM3 contains Glimepiride 2 mg + Metformin (SR) 500 mg + Voglibose 0.3 mg, a triple-action combination for effective type 2 diabetes management. Glimepiride stimulates insulin release, Metformin improves insulin sensitivity and lowers liver glucose production, while Voglibose delays carbohydrate absorption to control post-meal sugar spikes. This combination helps maintain stable blood sugar levels and supports long-term glycemic control.